84.96 USD
-0.31 (-0.36%)
84.96 USD
0 (0%)
Taking everything into account, LMAT scores 7 out of 10 in our fundamental rating. LMAT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. LMAT gets an excellent profitability rating and is at the same time showing great financial health properties. LMAT has a correct valuation and a medium growth rate. This makes LMAT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
LMAT had a positive operating cash flow in the past year.
Each year in the past 5 years LMAT has been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.92%, LMAT belongs to the best of the industry, outperforming 91.44% of the companies in the same industry.
The Return On Equity of LMAT (14.08%) is better than 90.37% of its industry peers.
LMAT has a Return On Invested Capital of 8.43%. This is amongst the best in the industry. LMAT outperforms 87.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LMAT is in line with the industry average of 8.82%.
The last Return On Invested Capital (8.43%) for LMAT is above the 3 year average (8.26%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROIC | 8.43% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
The Profit Margin of LMAT (22.14%) is better than 94.12% of its industry peers.
LMAT's Profit Margin has improved in the last couple of years.
LMAT has a better Operating Margin (25.71%) than 95.19% of its industry peers.
LMAT's Operating Margin has improved in the last couple of years.
LMAT's Gross Margin of 70.97% is fine compared to the rest of the industry. LMAT outperforms 79.14% of its industry peers.
LMAT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LMAT is destroying value.
LMAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LMAT has been increased compared to 5 years ago.
LMAT has a worse debt/assets ratio than last year.
2.2 Solvency
LMAT has an Altman-Z score of 7.29. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
LMAT has a Altman-Z score of 7.29. This is amongst the best in the industry. LMAT outperforms 85.03% of its industry peers.
LMAT has a debt to FCF ratio of 2.54. This is a good value and a sign of high solvency as LMAT would need 2.54 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.54, LMAT belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that LMAT is not too dependend on debt financing.
LMAT has a Debt to Equity ratio (0.44) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Altman-Z | 7.29 |
ROIC/WACC0.98
WACC8.59%
2.3 Liquidity
A Current Ratio of 13.58 indicates that LMAT has no problem at all paying its short term obligations.
LMAT has a better Current ratio (13.58) than 97.86% of its industry peers.
LMAT has a Quick Ratio of 11.45. This indicates that LMAT is financially healthy and has no problem in meeting its short term obligations.
LMAT has a Quick ratio of 11.45. This is amongst the best in the industry. LMAT outperforms 95.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 19.67% over the past year.
Measured over the past years, LMAT shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.13% on average per year.
Looking at the last year, LMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.07% in the last year.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.10% yearly.
The Revenue is expected to grow by 9.65% on average over the next years. This is quite good.
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 38.79 indicates a quite expensive valuation of LMAT.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.26. LMAT is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 32.20 indicates a quite expensive valuation of LMAT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 72.19% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of LMAT to the average of the S&P500 Index (23.68), we can say LMAT is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.79 | ||
| Fwd PE | 32.2 |
4.2 Price Multiples
LMAT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LMAT is cheaper than 76.47% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 79.14% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.11 | ||
| EV/EBITDA | 19.97 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LMAT has an outstanding profitability rating, which may justify a higher PE ratio.
LMAT's earnings are expected to grow with 14.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.4
PEG (5Y)2.26
EPS Next 2Y16.63%
EPS Next 3Y14.06%
5. Dividend
5.1 Amount
With a yearly dividend of 0.96%, LMAT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.19, LMAT pays a better dividend. On top of this LMAT pays more dividend than 93.05% of the companies listed in the same industry.
With a Dividend Yield of 0.96, LMAT pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.96% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has paid a dividend for at least 10 years, which is a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
LMAT pays out 32.20% of its income as dividend. This is a sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP32.2%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
84.96
-0.31 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.15%
Inst Owner Change-3.91%
Ins Owners7.89%
Ins Owner Change-5.26%
Market Cap1.93B
Revenue(TTM)240.87M
Net Income(TTM)53.34M
Analysts78.82
Price Target106.42 (25.26%)
Short Float %5.19%
Short Ratio6.81
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.96% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP32.2%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.59%
Min EPS beat(2)3.81%
Max EPS beat(2)7.38%
EPS beat(4)2
Avg EPS beat(4)0.79%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.68%
EPS beat(12)9
Avg EPS beat(12)4.66%
EPS beat(16)9
Avg EPS beat(16)-0.71%
Revenue beat(2)1
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.49%
Revenue beat(12)6
Avg Revenue beat(12)-0.01%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)-0.28%
PT rev (3m)-0.42%
EPS NQ rev (1m)3.93%
EPS NQ rev (3m)4.07%
EPS NY rev (1m)6.5%
EPS NY rev (3m)6.42%
Revenue NQ rev (1m)-1.4%
Revenue NQ rev (3m)-2.16%
Revenue NY rev (1m)-0.94%
Revenue NY rev (3m)-0.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.79 | ||
| Fwd PE | 32.2 | ||
| P/S | 8 | ||
| P/FCF | 29.11 | ||
| P/OCF | 26.31 | ||
| P/B | 5.09 | ||
| P/tB | 6.85 | ||
| EV/EBITDA | 19.97 |
EPS(TTM)2.19
EY2.58%
EPS(NY)2.64
Fwd EY3.11%
FCF(TTM)2.92
FCFY3.44%
OCF(TTM)3.23
OCFY3.8%
SpS10.62
BVpS16.7
TBVpS12.4
PEG (NY)1.4
PEG (5Y)2.26
Graham Number28.69
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.92% | ||
| ROE | 14.08% | ||
| ROCE | 10.97% | ||
| ROIC | 8.43% | ||
| ROICexc | 21.47% | ||
| ROICexgc | 38.36% | ||
| OM | 25.71% | ||
| PM (TTM) | 22.14% | ||
| GM | 70.97% | ||
| FCFM | 27.5% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexgc growth 3Y-0.4%
ROICexgc growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 2.54 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 68.51% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.46% | ||
| Profit Quality | 124.17% | ||
| Current Ratio | 13.58 | ||
| Quick Ratio | 11.45 | ||
| Altman-Z | 7.29 |
F-Score5
WACC8.59%
ROIC/WACC0.98
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)19.67%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%26.53%
EPS Next Y27.73%
EPS Next 2Y16.63%
EPS Next 3Y14.06%
EPS Next 5Y11.1%
Revenue 1Y (TTM)13.07%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%11.36%
Revenue Next Year12.78%
Revenue Next 2Y10.91%
Revenue Next 3Y10.19%
Revenue Next 5Y9.65%
EBIT growth 1Y24.85%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year45.26%
EBIT Next 3Y22.27%
EBIT Next 5YN/A
FCF growth 1Y189.96%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y143.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%
LEMAITRE VASCULAR INC / LMAT FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
Can you provide the valuation status for LEMAITRE VASCULAR INC?
ChartMill assigns a valuation rating of 5 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
How profitable is LEMAITRE VASCULAR INC (LMAT) stock?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the valuation of LEMAITRE VASCULAR INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LEMAITRE VASCULAR INC (LMAT) is 38.79 and the Price/Book (PB) ratio is 5.09.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 27.73% in the next year.